# Clinical Trial to Evaluate UV-light-induced Allergic Skin Reactions After Application of Delgocitinib Cream

> **NCT04807751** · PHASE1 · COMPLETED · sponsor: **LEO Pharma** · enrollment: 60 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Delgocitinib cream
- **DRUG:** Delgocitinib cream vehicle

## Key facts

- **NCT ID:** NCT04807751
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-25
- **Primary completion:** 2021-07-30
- **Final completion:** 2021-07-30
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2026-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04807751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04807751, "Clinical Trial to Evaluate UV-light-induced Allergic Skin Reactions After Application of Delgocitinib Cream". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04807751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*